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Infection with the AIDS virus itself (HIV, HTLV-III, LAV, ARV) is associated with a full
spectrum ofneurological disorders. The application ofdiagnostic studies for HTLV-III infection
has demonstrated that these neurologic disorders can be the first manifestation ofAIDS or occur
in the absence ofAIDS. The most common conditions associated with HTLV-III infection alone
are a subacute encephalopathy (AIDS dementia) and peripheral neuropathy; however, vacuolar
myelopathy and both acute and chronic aseptic meningitis are also common. Congenital (or
neonatal) transmission ofthe virus can result in a mental retardation syndrome ofdelayed onset.
The AIDS virus is neurotropic as well as targeting T-helper lymphocytes. The virus has been
readily identified in neural tissues and cerebrospinal fluid, including instances in which other
central nervous system infections, such as toxoplasmosis, coexist. Hence, recognition of an
appropriate syndrome, neurodiagnostic studies, and exclusion (or treatment) ofother infections,
as well as evidence for HTLV-III infection are required for diagnosis. The development of
successful therapy will require agents which cross the blood-brain barrier.
The acquired immunodeficiency syndrome (AIDS) virus (HIV, HTLV-III, LAV,
ARV) has tropism for both lymphocytes and the nervous system. The acquired
immunodeficiency syndrome and the massive opportunistic infections associated with
it result from the infection of the T-helper lymphocytes (T4) and their consequent
destruction. The immunodeficiency syndrome in its full-blown and lethal expression is,
however, only part of the disease spectrum. In this review we focus on the clinical
syndromes which result, from the effect of the AIDS virus itself on the nervous
system.
It was recognized relatively early that opportunistic central nervous system (CNS)
infections were common in AIDS patients [1]. Apart from the AIDS virus, the most
common cerebral infections have been cytomegalovirus (CMV) and toxoplasmosis
[2,3,4]; however, many other opportunistic infections have been documented (Table
1). Primary CNS lymphoma of B-cell origin [5] occurs, and the role of Epstein-Barr
virus (EBV) in these tumors requires further study [6]. Progressive multifocal
leukoencephalopathy, a condition associated with papovavirus infection ofthe brain in
settings of impaired cellular immunity, occurs with an increased frequency in AIDS.
Viral encephalitis or myelitis, particularly that caused by agents often seen in the
context of impaired cellular immunity, such as varicella-zoster virus (VZV), are also
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TABLE 1
Opportunistic Diseases of the Nervous System
in AIDS
Brain
Cytomegalovirus encephalitis
Toxoplasmosis
Central nervous system lymphoma
Progressive multifocal leukoencephalopathy
Other viral encephalitis (e.g., VZV, HSV)
Spinal cord
Myelitis (e.g., VZV, CMV, HSV)
Meninges
Cryptococcal meningitis
Aseptic meningitis (e.g., HSV-II)
Mycobacterial infections
Bacterial meningitis
Nerve roots
Shingles (VZV)
Cytomegalovirus (CMV)
found. Acute aseptic and chronic meningitis are frequent, with cryptococcus as a
common cause ofchronic meningitis.
Demonstration ofCNS infection by human T-cell lymphotrophic virus III (HTLV-
III) was first achieved in the investigation of the subacute encephalopathy of AIDS.
The potential cause ofthis condition, a subacute dementing illness with an inexorable
course, was thought to be viral, such as CMV or HTLV-Ill. Shaw et al. demonstrated
the DNA of HTLV-III in the brains offive of 15 cases ofAIDS encephalopathy, and
viral-specific RNA in four ofthose five [7]. Furthermore, the quantity ofHTLV-Ill in
these brains was sometimes greater than that found in lymphoid tissues. Subsequent
studies by Levy et al. [8] and Ho et al. [9] have confirmed the finding of the AIDS
virus in the brain and have identified it in the cerebrospinal fluid (CSF). In addition,
Ho and his colleagues have found the virus in the spinal cord and in peripheral nerves
[9]. In a study of intra-blood-brain-barrier synthesis of antiviral antibody, Resnick et
al. concluded that infection of the nervous system by the AIDS virus occurred in the
majority of AIDS patients with neurologic symptoms [10]. Hence, there is strong
evidence based on several types of data that the virus of AIDS infects the human
nervous system. The presence of mRNA for T4 (the AIDS virus receptor) in human
cerebral cortex has been reported by Maddon et al. [11]. Other studies, described
below, have examined the cell types containing the virus.
With the widespread application of tests specific for the AIDS virus, it has become
apparent that many neurologic syndromes are not the result ofsuperimposed infections
but result from the AIDS virus itself. While the viral or host defense mechanism(s)
responsible for these syndromes remain a topic of intense investigation, their clinical
delineation has become clear. All levels of the nervous system can suffer as a direct
consequence ofAIDS virus infection (Table 2). Briefdescriptions of these syndromes
follow.
PROGRESSIVE ENCEPHALOPATHY OF INFANTS
In a proportion of children with AIDS, the risk factor is use of blood products or
transfusions. For the majority of infants two years or younger, particularly for those
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TABLE 2
Neurological Disorders Associated with Infection by the AIDS
Virus Itself
Brain
Congenital (or neonatal) infection
Retardation ofdelayed onset
Adult or childhood infection
AIDS dementia (subacute encephalopathy)
Acute encephalopathy
Granulomatous angiitis
Spinal cord
Vacuolar myelopathy
Meninges
Acute aseptic meningitis
Chronic aseptic meningitis
Peripheral nerves
Distal symmetric sensorimotor neuropathy
Mononeuritis multiplex
Chronic inflammatory demyelinating polyradiculoneuropathy
Guillain-Barr6 syndrome
Muscles
Polymyositis
less than a year old, however, it is the presence of a risk factor in a parent [12]. This
fact raises the possibility that the AIDS virus infection is transmitted transplacentally
during gestation or by an infected birth canal [13] at delivery. Such infants are at risk
for developing a progressive and ultimately fatal encephalopathy. After a variable
period of apparently normal development, loss of motor milestones and intellectual
regression occur [14-16]. Pyramidal tract signs, myoclonicjerks, ataxia, seizures, and
microcephaly can be observed clinically and cortical atrophy demonstrated on CT
scanning. Pathological changes are most frequently found in the basal ganglia, pons,
and white matter [16]. Nucleic acid hybridization studies have demonstrated the
presence of the viral genome in the brain [7] and electron microscopy has identified
retroviral particles in multinucleated giant cells in the brain [16]. The molecular
pathogenesis ofthe progressive encephalopathy ofinfants and children, however, as in
adults, remains unknown.
AIDS DEMENTIA (SUBACUTE ENCEPHALOPATHY)
A subacute dementing process associated with AIDS, variously termed a subacute
encephalitis, subacute encephalopathy, or AIDS dementia, is the most common CNS
disorder associated with the AIDS virus [17]. It results from infection with the AIDS
virus itselfrather than from superinfection with anotherorganism [7,16,18]. Theonset
is most often subtle and difficult to distinguish from other processes which afflict
AIDS patients. Thus, apathy, reduced concentration, and impaired recent memory can
also result from depression or a metabolic encephalopathy secondary to other organ
dysfunction. On occasion, the presentation is more dramatic, with agitation and an
apparent acute psychosis. In patients without documented AIDS or AIDS-related
complex (ARC), the presence of a risk factor and residence in an epidemic center
should raise the suspicion ofan AIDS virus-induced dementia. Over a course ofweeks
to months, patients progressively lose motor function, and become globally demented,
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and many experience myoclonus or seizures. In the end stage, such unfortunate
individuals are bed-bound, quadriparetic, doubly incontinent, and severely demented.
Early in the course of the dementia, the most important consideration is to exclude
potentially treatable infections such as toxoplasmosis infection of the brain or fungal
meningitis. Unfortunately, there is no specifically diagnostic test for AIDS dementia.
Even identification of HTLV-III in the CSF does not exclude the possibility of the
simultaneous presence of another infection. The CT scan may demonstrate atrophy
and whitematterattenuation. Thelumbar puncture oftendemonstrates a mononuclear
pleocytosis and somewhat elevated protein and may contain oligoclonal bands of IgG.
Although special studies have demonstrated the production of viral-specific IgG
antibody in the CSF [10], such antibodydoes not exclude the presence ofan additional
infection. The EEG frequently demonstrates nonspecific bilateral abnormalities.
Effective specific antiviral therapy will require the capacity to penetrate the blood-
brain barrier.
In addition to the multinucleated giant cell, the principal cell containing thevirus in
the brain appears to be the monocyte. Several lines ofevidence, including immunohis-
tology [18,19], in situ hybridization [19,20], and characterization ofcells from which
virus has been isolated in vitro [21], demonstrate the monocyte/macrophage to be the
principal target. The role of capillary endothelial cells has been emphasized in one
study [19]. Less frequently, neurons and glia have evidence of infection [19,20].
Koenig et al., however, combined in situ hybridization and cytochemical techniques to
demonstrate that over 93 percent of cells producing viral RNA were of macrophage
lineage [22].
ACUTE ENCEPHALOPATHY
Many of the syndromes discussed in this review occur in the setting of established
HTLV-III infection and represent subacute or chronic responses to persistent infec-
tion. Other entities, however, including an acute encephalopathy, appear to result from
initial infection with the AIDS virus. Carne et al. [23] have described three patients
who experienced a reversible encephalopathy. In two ofthese patients, seroconversion
for HTLV-III antibody was demonstrated at the time of the encephalopathy. The
illnesses were characterized by prodromes of fever, malaise, forgetfulness, and
personality change. Two ofthe patients experienced seizures. All recovered from these
particular illnesses. This syndrome appears to be quite uncommon, and its mechanism
is unknown.
CEREBRAL GRANULOMATOUS ANGIITIS
Granulomatous angiitis ofthe CNS is an uncommon condition resulting in multiple
infarcts. It is sometimes associated with evidence of VZV infection. Yankner et al.
have reported a case in which no VZV activity was found, and which appeared to result
from an early infection with the AIDS virus [24]. Virus was recovered from the CSF
and brain biopsy of a 42-year-old homosexual male with a progressive neurologic
disorder. Testing for serum antibody totheAIDS virus was negative. Autopsy revealed
multiple infarcts ofvarious ages, inflammation of all layers of involved arteries, focal
necrosis with fragmentation of the internal elastic lamina, and fibrous internal
scarring. Multinucleated giant cells wereobserved, usually in the region ofthe internal
elastic lamina. The case would appear to represent another early manifestation of
AIDS virus infection.
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VACUOLAR MYELOPATHY AND OTHER SPINAL CORD CONDITIONS
Petito and hercolleagues have identified avacuolar myelopathy in over 20 percentof
a large series ofAIDS patients coming to autopsy [25]. Microscopically characterized
by vacuolation ofwhite matter in the presence oflipid-laden macrophages, it was most
severe in the posterior and lateral columns of the spinal cord. Clinically it is
characterized by a progressive paraparesis with spasticity, ataxia, and thedevelopment
ofurinary incontinence. Clinical recognition may sometimes be difficult because ofthe
simultaneous presence of AIDS dementia with its associated impairment of motor
function. Thus, 70 percent ofcases reported by Petito et al. were demented [25]. This
syndrome does not present as a transverse myelitis. If an acute transverse myelitis
occurs in an AIDS patient, a thorough search for treatable infections must be made
after a compressive lesion has been excluded. For example, varicella-zoster-associated
myelitis merits treatment with acyclovir.
A patient has been reported in whom amyotrophic lateral sclerosis and LAV/
HTLV-III infection appeared to be temporally linked [26]. Previous studies of a
murine retrovirus have demonstrated the experimental induction of anterior horn cell
disease in mice [27]. Clinically, the importance of the AIDS virus for motor neuron
syndromes is unclear. In another case report, spinal myoclonuswith negative spinal CT
and MRI studies has been described in an otherwise asymptomatic homosexual man
[28]. The CSF contained antibody against HTLV-III. The spinal myoclonus was
distinguished from generalized myoclonus, which can be associated with AIDS
encephalopathy.
ASEPTIC MENINGITIS
Patients with AIDS and ARC experience aseptic meningitis in a variety of forms.
Acute self-limiting [1], recurring, chronic, and complicated forms [29] of aseptic
meningitis are encountered. Furthermore, a chronic CSF pleocytosis without menin-
geal signs can be a worrisome finding in this population. HTLV-III infection can itself
beassociated with acuteasepticmeningitis [9,10] and alsowith chronic meningitis [9].
It isclearly important toexclude other treatable infections such asfungal meningitis in
this population. It is also worth noting that the homosexual male population is at risk
for herpes simplexvirus (HSV)-II aseptic meningitis and thatsuch casesmightdeserve
a therapeutic trial of acyclovir. Once other treatable processes have been excluded,
however, the knowledge that HTLV-III is associated with aseptic meningitis may
temper repeated efforts to find other infections ifthe clinical condition is stable.
PERIPHERAL NEUROPATHY
Progressive distal symmetric sensorimotor neuropathy is common in patients with
AIDS or ARC [1,29]. Usually the neuropathy presents with dysasthesias and can
progress to sensory loss, distal weakness, and atrophy. Also observed in patients
infected by HTLV-III are mononeuritis multiplex, chronic inflammatory demyelinat-
ing polyradiculoneuropathy, and acute Guillain-Barre syndrome. Patients with inflam-
matory demyelinating neuropathies may be seropositive for the AIDS virus but have
no clinical evidence of AIDS or ARC [30]. Nerve conduction studies reveal demyeli-
nating patterns, and nerve biopsies demonstrate demyelination and inflammation.
CSF proteins are elevated, and a pleocytosis is usually found. It has been reported that
patients with chronic inflammatory demyelinating polyradiculoneuropathy benefit
from plasma exchange [30,31].
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POLYMYOSITIS
Two cases of polymyositis in homosexual men have been reported by Dalakas et al.
[32]. Serologically positive for HTLV-Ill antibody, neither patient had ARC or AIDS
at presentation but later developed these conditions. Viral antigens were identified in
the T4 lymphocytes invading muscle but not in the muscle cells themselves. Both
patients were treated with steroids, resulting in significant clinical improvement in
one.
CONCLUSIONS
It is important to recognize the clinical patterns of neurologic disease associated
with HTLV-III infection. It has become apparent that significant disability, such as
the dementia syndrome, can result from HTLV-III infection in the absence of AIDS.
Hence, physicians must maintain a high level of clinical suspicion, particularly in
epidemicareas, seekthe presenceofriskfactors, anddoserologictesting. In lightofthe
continuing increase of the AIDS epidemic in the U.S. and the potential for increased
heterosexual transmission, as in Africa, it is likely that the incidence of AIDS
virus-related neurologic conditions will continue to increase.
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